Cispoly
3 known investors
Find your way into Cispoly
Sign up to see every warm intro you have to Cispoly
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cispoly team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CisPoly develops non-invasive early cancer screening and diagnostic tests based on DNA methylation, targeting three major gynecological cancers: cervical, endometrial, and ovarian cancer. Its products are aimed at women's health and clinical use, supported by prospective multicenter clinical trials and published research.
Investors · 3
How we know: Prosperity7 Ventures's portfolio page · womenstabloid.com · funding news · Not right? Tell us
How we know: techzi.co · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJan 2024
Prosperity7 Ventures (lead), Sunland Fund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Cispoly do?
- CisPoly develops non-invasive early cancer screening and diagnostic tests based on DNA methylation, targeting three major gynecological cancers: cervical, endometrial, and ovarian cancer. Its products are aimed at women's health and clinical use, supported by prospective multicenter clinical trials and published research.
- Who are Cispoly's investors?
- Cispoly's investors include Prosperity7 Ventures, Aramco Ventures.

